Duopharma Biotech Berhad (7148.KL)
MYR 1.24
(-0.8%)
MYR 1.24
(-0.8%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 51.55 Million | 70.26 Million | 43.2 Million | 71.34 Million | 66.95 Million | 72.33 Million |
| Net Income | 52.64 Million | 84.85 Million | 82.98 Million | 76.15 Million | 70.8 Million | 59.66 Million |
| Depreciation & Amortization | 43.05 Million | 36.19 Million | 31.95 Million | 29.06 Million | 26.85 Million | 24.72 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -46.3 Million | -58.29 Million | -61.93 Million | -29.29 Million | -22.79 Million | -18.1 Million |
| Other non-cash items | 134.56 Million | 7.5 Million | -9.8 Million | -4.57 Million | -7.91 Million | 6.04 Million |
| Investing Cash Flow | -45.98 Million | -69.5 Million | -115.85 Million | -61.42 Million | -59.42 Million | -170.35 Million |
| Investments in PPE | -39.56 Million | -71.02 Million | -115 Million | -65.61 Million | -60.88 Million | -92.75 Million |
| Acquisitions | - | - | 21 Thousand | 9.5 Million | - | - |
| Investment purchases | -6.42 Million | - | -2.07 Million | -21.91 Million | - | -79.71 Million |
| Sales/Maturities of investments | - | - | -21 Thousand | 24.59 Million | - | - |
| Other Investing Activities | -3.86 Million | 1.52 Million | 1.21 Million | -7.99 Million | 1.46 Million | 2.11 Million |
| Financing Cash Flow | 107.52 Million | 18.19 Million | 52.36 Million | 27.83 Million | 15.03 Million | 100.41 Million |
| Debt repayment | -117.21 Million | -58.55 Million | -88.68 Million | -157.95 Million | -23.34 Million | -12.47 Million |
| Dividends payments | -8.85 Million | -8.2 Million | -44.95 Million | -7.23 Million | -6.06 Million | -13.16 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -857 Thousand | 84.95 Million | 186 Million | 193.02 Million | 44.44 Million | 126.04 Million |
| Accounts receivables | -5.81 Million | -13.27 Million | -4.14 Million | 4.54 Million | -19.55 Million | -13.88 Million |
| Accounts payables | -28.1 Million | 8.34 Million | 20.64 Million | -12.47 Million | 12.27 Million | 12.1 Million |
| Inventory | -12.39 Million | -53.36 Million | -78.43 Million | -21.36 Million | -15.51 Million | -16.33 Million |
| Other working capital | -8.19 Million | - | - | - | - | -1.77 Million |
| Cash at beginning of period | 157.63 Million | 137.98 Million | 158.02 Million | 120.66 Million | 98.25 Million | 96.02 Million |
| Cash at end of period | 270.5 Million | 157.63 Million | 137.98 Million | 158.02 Million | 120.66 Million | 98.25 Million |
| Capital Expenditure | -39.56 Million | -71.02 Million | -115 Million | -65.61 Million | -60.88 Million | -92.75 Million |
| Effect of forex changes on cash | -228 Thousand | 694 Thousand | 240 Thousand | -396 Thousand | -154 Thousand | -158 Thousand |
| Net cash flow / Change in cash | 112.86 Million | 19.65 Million | -20.04 Million | 37.36 Million | 22.41 Million | 2.23 Million |
| Free Cash Flow | 11.99 Million | -756 Thousand | -71.8 Million | 5.73 Million | 6.06 Million | -20.42 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 16.68 Million | 15.27 Million | 52.64 Million | 8.5 Million | 11.42 Million | 16.51 Million |
| Depreciation & Amortization | 11.34 Million | 11.31 Million | 43.05 Million | 14.2 Million | 10.28 Million | 9.31 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -33.98 Million | -26.31 Million | -46.3 Million | 25.66 Million | -7.74 Million | -5.23 Million |
| Other non-cash items | 61.91 Million | 50.67 Million | 134.56 Million | -883 Thousand | -2.96 Million | -5.24 Million |
| Investing Cash Flow | -6.2 Million | -4.24 Million | -45.98 Million | -13.17 Million | -14.83 Million | -3.23 Million |
| Investments in PPE | -6.2 Million | -4.24 Million | -39.56 Million | -13.17 Million | -8.8 Million | -3.72 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | -6.42 Million | - | -6.42 Million | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 586 Thousand | - | - | - | 393 Thousand | 490 Thousand |
| Financing Cash Flow | -5.04 Million | -35.77 Million | 107.52 Million | -42.93 Million | 149.87 Million | -4.14 Million |
| Debt repayment | -4.42 Million | -18.19 Million | -117.21 Million | -42.67 Million | -230.3 Million | -19.52 Million |
| Dividends payments | - | -17.31 Million | -8.85 Million | - | -4.81 Million | -4.04 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -625 Thousand | - | -857 Thousand | -267 Thousand | 384.99 Million | 15.38 Million |
| Accounts receivables | -65.95 Million | -13.73 Million | -5.81 Million | 21.28 Million | 7.56 Million | 9.5 Million |
| Accounts payables | 17.52 Million | -10.94 Million | -28.1 Million | -4.79 Million | -17.13 Million | -4.66 Million |
| Inventory | 14.45 Million | -1.64 Million | -12.39 Million | 9.16 Million | 1.83 Million | -10.07 Million |
| Other working capital | 17.52 Million | - | -8.19 Million | -8.19 Million | - | - |
| Cash at beginning of period | 232.32 Million | 270.5 Million | 157.63 Million | 281.88 Million | 135.56 Million | 127.88 Million |
| Cash at end of period | 221.16 Million | 232.32 Million | 270.5 Million | 270.5 Million | 281.88 Million | 135.56 Million |
| Capital Expenditure | -6.2 Million | -4.24 Million | -39.56 Million | -13.17 Million | -8.8 Million | -3.72 Million |
| Effect of forex changes on cash | 797 Thousand | -163 Thousand | -228 Thousand | -15 Thousand | 272 Thousand | -289 Thousand |
| Net cash flow / Change in cash | -11.15 Million | -38.18 Million | 112.86 Million | -11.38 Million | 146.31 Million | 7.68 Million |
| Free Cash Flow | -6.91 Million | -2.24 Million | 11.99 Million | 31.56 Million | 2.2 Million | 11.62 Million |
UNIVASTU
EPM
DIXON
TANAA
DEI
FIRST-B